KREMEN2
Kremen protein 2
Also known as: KREM2_HUMAN, KRM2, MGC10791
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NCW0
- Gene
- KREMEN2
- Ensembl
- ENSG00000131650
- Chromosome
- 16
- Canonical length
- 462 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a high-affinity dickkopf homolog 1 (DKK1) transmembrane receptor. A similar protein in mouse functions interacts with with DKK1 to block wingless (WNT)/beta-catenin signaling. The encoded protein forms a ternary membrane complex with DKK1 and the WNT receptor lipoprotein receptor-related protein 6 (LRP6), and induces rapid endocytosis and removal of LRP6 from the plasma membrane. It contains extracellular kringle, WSC, and CUB domains. Alternatively spliced transcript variants encoding distinct isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
462 residues, UniProt reviewed canonical sequence.
>Q8NCW0|KREMEN2
1 MGTQALQGFL FLLFLPLLQP RGASAGSLHS PGLSECFQVN GADYRGHQNR TGPRGAGRPC
61 LFWDQTQQHS YSSASDPHGR WGLGAHNFCR NPDGDVQPWC YVAETEEGIY WRYCDIPSCH
121 MPGYLGCFVD SGAPPALSGP SGTSTKLTVQ VCLRFCRMKG YQLAGVEAGY ACFCGSESDL
181 ARGRLAPATD CDQICFGHPG QLCGGDGRLG VYEVSVGSCQ GNWTAPQGVI YSPDFPDEYG
241 PDRNCSWALG PPGAALELTF RLFELADPRD RLELRDAASG SLLRAFDGAR PPPSGPLRLG
301 TAALLLTFRS DARGHAQGFA LTYRGLQDAA EDPEAPEGSA QTPAAPLDGA NVSCSPRPGA
361 PPAAIGARVF STVTAVSVLL LLLLGLLRPL RRRSCLLAPG KGPPALGASR GPRRSWAVWY
421 QQPRGVALPC SPGDPQAEGS AAGYRPLSAS SQSSLRSLIS ALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KREMEN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 7.5 nTPM
Expression across tissuesHPA
Tissue
- skin: 7.5 nTPM
- retina: 3.8 nTPM
- thymus: 2 nTPM
- esophagus: 1.9 nTPM
- cerebral cortex: 1.8 nTPM
- testis: 1.7 nTPM
Single-cell type
- tuft cells: 46 nCPM
- rod photoreceptor cells: 33 nCPM
- early primary spermatocytes: 30 nCPM
- goblet cells: 19 nCPM
- medullary thymic epithelial cells: 17 nCPM
- epididymal basal cells: 15 nCPM
Immune cell
- naive B-cell: 1.3 nTPM
- memory B-cell: 1.2 nTPM
- non-classical monocyte: 0.4 nTPM
- myeloid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 9.1 nTPM
- hippocampal formation: 8 nTPM
- amygdala: 7.7 nTPM
- white matter: 6.6 nTPM
- basal ganglia: 5.3 nTPM
- medulla oblongata: 4.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.51
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KREMEN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KREMEN2 as an antibody target. Whether an autoantibody or antibody against KREMEN2 could matter depends on whether native KREMEN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KREMEN2 is annotated at the cell surface, where native KREMEN2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KREMEN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...